Managers

BriaCell Therapeutics raises $5.3 mln from U.S. biotech funds

Vancouver and Berkeley, California-based BriaCell Therapeutics Corp (TSX-V: BCT), an immuno-oncology-focused biotechnology company, has raised about $5.3 million in financing. According to details of a non-brokered private placement, BriaCell sold over 43 million shares of the company at $0.10 per share. In addition to this deal, BriaCell raised US$800,000 (about $1 million) in a brokered private placement. The U.S. life sciences investors included Brio Capital Master Fund, Efrat Investments and Mario Family Partners. The proceeds will be used to fund BriaCell's Phase-2a clinical trial, to pursue research opportunities, and for other priorities.

Lightspeed seeks to raise $1.8 bln

Lightspeed Venture Partners, which last year saw exits in the unicorn companies AppDynamics, Mulesoft and Snap, is seeking to raise $1.8 billion for Lightspeed Venture Partners Select III, according to a regulatory filing. In 2016, the firm raised more than a combined $1.2 billion for two funds, including $715 million for its 11th early-stage fund and $500 million for Lightspeed Venture Partners Select II. The Select Fund invests in follow-on rounds, primarily in existing Lightspeed portfolio companies.

Midwest healthcare investing spikes in 2017 on Outcome deal

Bullpen to raise $165 mln for two funds, including fourth core fund

Bullpen Capital has set out to raise $165 million for two funds, including a fourth core fund, according to filings with the SEC.

General Catalyst raises $1.4 bln for ninth venture fund

General Catalyst has raised the full $1.38 billion targeted for its ninth venture fund, according to a regulatory filing. With offices in Cambridge, San Francisco, Palo Alto, and New York City, the firm makes early-stage and growth equity investments.

Genetically engineering your diet? Startups tell you how to nourish based on your DNA.

Venture debt sees opportunities with pre-IPO unicorns

Cendana to raise $40 mln international fund of funds

Cendana Capital has set out to raise a $40 million international fund of funds, according to a filing with the SEC.

Samsara BioCapital raises $260.6 mln for venture capital fund

Samsara BioCapital has raised $260.6 million toward a $300 million venture-capital fund, according to a filing with the SEC.

Ecosystem Integrity Fund raises $41 mln toward targeted $100 mln third fund

Ecosystem Integrity Fund has raised $41.1 million toward a targeted $100 million for its third venture fund, according to a regulatory filing.